Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chaiqin Lidan Granules
- Development stage
- Unknown
- Lead developer
- Anhui Institute of Materia Medica
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Chaiqin Lidan Granules is a Traditional Chinese Medicine (TCM) formulation developed by the Anhui Institute of Pharmaceutical Research for the treatment of chronic cholecystitis and related biliary disorders. The preparation is composed of several herbal ingredients, most notably *Bupleurum chinense* (Chaihu) and *Scutellaria baicalensis* (Huangqin), which work synergistically to clear heat, resolve dampness, and soothe the liver and gallbladder. Pharmacologically, the granules exhibit choleretic properties by increasing bile production and flow, as well as anti-inflammatory and analgesic effects that mitigate the symptoms of gallbladder inflammation. It is widely used in China to manage symptoms such as hypochondriac pain, bitterness in the mouth, and jaundice associated with damp-heat in the liver and gallbladder.
- Brand names
- Chaiqin Lidan Granules
- Other names
- Chai Qin Li Dan Ke LiChaiqin Lidan Keli
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))PTGS2 (Prostaglandin-Endoperoxide Synthase 2)
Beyond the preview
Go deeper on Chaiqin Lidan Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chaiqin Lidan Granules.